Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
Drug Transporter (DT) Information
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0122 | ||||
| Gene Name | SLC17A9 | ||||
| Protein Name | Solute carrier family 17 member 9 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
Modelled DT Structure Method: multi-sequence alignment based machine learning Detail: Structure Info |
||||
| Synonyms | C20orf59; SLC17A9; Solute carrier 17 member 9 | ||||
| DT Family | Major Facilitator Superfamily (MFS) | ||||
| Anion:Cation Symporter (ACS) Family | |||||
| Tissue Specificity | Predominantly expressed in adrenal gland,brain and thyroid. | ||||
| Function | This transporter mediates vesicular storage and exocytosis of adenosine triphosphate. Adenosine triphosphate and other nucleotides can be accumulated in secretory vesicles such as adrenal chromaffin granules and synaptic vesicles. | ||||
| Endogenous Substrate(s) | ADP; ATP; GTP | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.